AINOSTICS has just been given the go-ahead to start work on its second substantial Innovate UK funded project, secured in the space of less than 6 months!
As part of this work, AINOSTICS will be looking at novel AI-driven imaging-based biomarkers for dementia diagnosis, stratification and staging, crucial for enabling earlier, more accurate and targeted interventions, as well as delivering a powerful new tool for use in current and future trials of therapies aimed at neurodegenerative conditions.